MedTrace Logo

Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction

NCT00657644 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2014-12-25

No results posted yet for this study

Summary

To find out more information on how effective and safe vardenafil is at treating impotence in men living in Russia.

Conditions

Interventions

DRUG

Levitra (Vardenafil, BAY38-9456)

4 weeks treatment with 10 mg vardenafil followed by a flexible titration phase for 8 weeks

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-08-31
Primary Completion
2004-03-31
Completion
2004-03-31

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00657644 on ClinicalTrials.gov